Addiction

Investigators found that among adolescents that began as never users, e-cigarette users were more likely to become experimental, infrequent or frequent combustible cigarette users.

Young people who inject drugs tell why they do not—or cannot— receive treatment for hepatitis C virus infection.

A new meta-analysis finds people who were recently incarcerated face significantly higher risks of contracting hepatitis C and HIV infection.

Investigators have found an association between opioid use and cardiovascular mortality.

There are 3 FDA-approved medications available to treat opioid use disorder, and different treatment approaches that can aid patients on the road to recovery.

Added stigma further burdens the treatment of patients with opioid use disorder, but the medical community can do something about it.

Lindsey Jennings, MD, MPH, and Carolyn Bogdon, MSN, FNP-BC, of Medical University of South Carolina discuss the challenges facing health care providers who are on the front line of battling the opioid epidemic.

The most reliable practice for helping a patient quit is comprehensive, and catered to their medical, physical, and financial goals.

Coverage of the post-surgery pain management therapy's strength has overlooked its clinical setting use and potential need.

People who are addicted to drugs face a higher risk of contracting HCV. Yet, a new study suggests the majority teens who are addicted to opioids don’t get screened for the virus.

Active-duty military personnel report a deadly opioid overdose rate just one-fourth of the general population. What does the military do with its patient registries that could be repeatable in public health?

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.

A meta-analysis shows the experimental therapy has favorable benefits for certain aspects of pain, as well as preferrable avenues of administration.

Evidence from a number of countries suggests that America’s expansion of opioid addiction treatment programs will pay dividends in curbing rates of HIV transmission among people who inject drugs.

After 10 days of transcranial magnetic stimulation, patients reported significant decreases in withdrawal symptoms like craving, quality of sleep, and mood status.

The sublingual film therapy has been approved under a 16 mg/ 4 mg dosage strength for the maintenance treatment of opioid dependence, adding to therapy options which include both brand name and generic versions.

The FDA has granted an orphan drug designation to Antidote Therapeutics, Inc.’s ATI-1013 for the treatment of Buerger’s disease.

The director of Pain Management and Palliative Care at the Englewood Hospital & Medical Center in Englewood, NJ, explains how analgesics may come to the forefront of pain management care.

How issues with pain in patients with Lyme disease or opioid-induced constipation can be managed in a timely, efficient manner.

New research finds patients hospitalized for alcohol dependence have lower rates of survival if they are also infected with hepatitis C.

The 30-person panel, including physicians and patients, recommended a median 12.5 tablets of 5mg opioid for 20 common procedures.

From 1999 to 2014, prevalence of opioid use disorder among women giving birth increased 333% nationally, according to a report from the Centers for Disease Control and Prevention.

The FDA accepted the NDA for NKTR-181, a drug with slowed entry into the brain that attenuates the dopamine release underlying euphoria.

Recent reports have suggested a higher-than-expected rate of problematic drinking among the elderly, prompting an examination of a number of factors that could be utilized as future predictors of alcohol-related outcomes.

New research finds patients with HIV and chronic pain are aware that opioids are addictive, yet most don’t receive common addiction-prevention monitoring.